Serum Gonadotropin Levels Predict Post-Trigger Luteinizing Hormone Response in Antagonist Controlled Ovarian Hyperstimulation Cycles

被引:2
作者
Wiltshire, Ashley [1 ]
Tozour, Jessica [2 ]
Hamer, Dina [3 ]
Akerman, Meredith [4 ]
McCulloh, David H. [1 ]
Grifo, James A. [1 ]
Blakemore, Jennifer [1 ]
机构
[1] New York Univ Langone Fertil Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 660 1st Ave, New York, NY 10016 USA
[2] New York Univ Langone Hosp Long Isl, Dept Obstet & Gynecol, 259 1st St, Mineola, NY 11501 USA
[3] New York Univ, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA
[4] New York Univ, Div Hlth Serv Res, Biostat Core, Langone Hosp Long Isl, 101 Mineola Blvd,Suite 3-041, Mineola, NY 11501 USA
关键词
Gonadotropin; Antagonist; Trigger; In vitro fertilization; GNRH AGONIST; OOCYTE MATURATION; SUBOPTIMAL RESPONSE; MUTATIONS; RISK;
D O I
10.1007/s43032-022-01105-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The objective of this study was to investigate the utility of using serum gonadotropin levels to predict optimal luteinizing hormone (LH) response to gonadotropin releasing hormone agonist (GnRHa) trigger. A retrospective cohort study was performed of all GnRH-antagonist controlled ovarian hyperstimulation (COH) cycles at an academic fertility center from 2017-2020. Cycles that utilized GnRHa alone or in combination with human chorionic gonadotropin (hCG) for trigger were included. Patient and cycle characteristics were collected from the electronic medical record. Optimal LH response was defined as a serum LH >= 40 mIU/mL on the morning after trigger. Total sample size was 3865 antagonist COH cycles, of which 91% had an optimal response to GnRHa trigger. Baseline FSH (B-FSH) and earliest in-cycle LH (EIC-LH) were significantly higher in those with optimal response. Multivariable logistic regression affirmed association of optimal response with EIC-LH, total gonadotropin dosage, age, BMI and Asian race. There was no difference in the number of oocytes retrieved (p = 0.14), maturity rate (p = 0.40) or fertilization rates (p = 0.49) based on LH response. There was no difference in LH response based on use of combination vs. GnRHa alone trigger (p = 0.21) or GnRHa trigger dose (p = 0.46). The EIC-LH was more predictive of LH trigger response than B-FSH (p < 0.005).The optimal B-FSH and EIC-LH values to yield an optimal LH response was >= 5.5 mIU/mL and >= 1.62 mIU/mL, respectively. In an era of personalized medicine, utilizing cycle and patient characteristics, such as early gonadotropin levels, may improve cycle outcomes and provide further individualized care.
引用
收藏
页码:1335 / 1342
页数:8
相关论文
共 14 条
[1]   Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response [J].
Chang, Frank E. ;
Beall, Stephanie A. ;
Cox, Jeris M. ;
Richter, Kevin S. ;
DeCherney, Alan H. ;
Levy, Michael J. .
FERTILITY AND STERILITY, 2016, 106 (05) :1093-+
[2]   Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol [J].
Chen, Shi-Ling ;
Ye, De-Sheng ;
Chen, Xin ;
Yang, Xin-Hong ;
Zheng, Hai-Yan ;
Tang, Yan ;
He, Yu-Xia ;
Guo, Wei .
HUMAN REPRODUCTION, 2012, 27 (05) :1351-1356
[3]   GnRH receptor mutations in isolated gonadotropic deficiency [J].
Chevrier, L. ;
Guimiot, F. ;
de Roux, N. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 346 (1-2) :21-28
[4]   Measurement of Luteinizing Hormone Level After Gonadotropin-Releasing Hormone Agonist Trigger Is Not Useful for Predicting Oocyte Maturity [J].
Dunne, Caitlin ;
Shan, Angel ;
Nakhuda, Gary .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2018, 40 (12) :1618-1622
[5]   The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study [J].
Engmann, Lawrence ;
DiLuigi, Andrea ;
Schmidt, David ;
Nulsen, John ;
Maier, Donald ;
Benadiva, Claudio .
FERTILITY AND STERILITY, 2008, 89 (01) :84-91
[6]   IDENTIFICATION OF 2 POINT MUTATIONS IN THE GENE CODING LUTEINIZING-HORMONE (LH) BETA-SUBUNIT, ASSOCIATED WITH IMMUNOLOGICALLY ANOMALOUS LH VARIANTS [J].
FURUI, K ;
SUGANUMA, N ;
TSUKAHARA, S ;
ASADA, Y ;
KIKKAWA, F ;
TANAKA, M ;
OZAWA, T ;
TOMODA, Y .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01) :107-113
[7]   OCCURRENCE AND BIOLOGICAL PROPERTIES OF A COMMON GENETIC VARIANT OF LUTEINIZING-HORMONE [J].
HAAVISTO, AM ;
PETTERSSON, K ;
BERGENDAHL, M ;
VIRKAMAKI, A ;
HUHTANIEMI, I .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (04) :1257-1263
[8]   Suboptimal response to GnRH agonist trigger: causes and practical management [J].
Humaidan, Peter ;
Kol, Shahar .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (03) :213-217
[9]   Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction [J].
Ludwig, M ;
Felberbaum, RE ;
Devroey, P ;
Albano, C ;
Riethmüller-Winzen, H ;
Schüler, A ;
Engel, W ;
Diedrich, K .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 264 (01) :29-32
[10]   GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study [J].
Melo, M. ;
Busso, C. E. ;
Bellver, J. ;
Alama, P. ;
Garrido, N. ;
Meseguer, M. ;
Pellicer, A. ;
Remohi, J. .
REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (04) :486-492